Healthcare - Biotechnology - NASDAQ - US
$ 49.58
-7.45 %
$ 5.52 B
Market Cap
-53.89
P/E
Price Target
Average
123.68%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
28.40%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Viking Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for VKTX of $111 , with forecasts ranging from a low of $90 to a high of $138 .
VKTX Lowest Price Target
Wall Street Target
90 USD
81.52%
VKTX Average Price Target
Wall Street Target
111 USD
123.68%
VKTX Highest Price Target
Wall Street Target
138 USD
178.34%
REVENUE FORECAST
Revenue Forecast Chart VKTX
EBIT FORECAST
EBIT Forecast Chart VKTX
NET INCOME FORECAST
Net Income Chart VKTX